posted
I had the proper amount of shares arrive in my Ameritrade account the problem is that under the Symbol section of my balance and positions page it says N/A. Hopefully a SLSE appears soon so I can make some money.
IP: Logged |
quote:Originally posted by gumzsa: I had the proper amount of shares arrive in my Ameritrade account the problem is that under the Symbol section of my balance and positions page it says N/A. Hopefully a SLSE appears soon so I can make some money.
-------------------- " A man's got to know his limitations." Clint Eastwood in Magnum Force
IP: Logged |
quote:Originally posted by gumzsa: I had the proper amount of shares arrive in my Ameritrade account the problem is that under the Symbol section of my balance and positions page it says N/A. Hopefully a SLSE appears soon so I can make some money.
Mine just showed up under the symbol SOLOS not SLSE and I recive 1 for 120 not 1 for 100 as they said in their first news release !!!
-------------------- " A man's got to know his limitations." Clint Eastwood in Magnum Force
IP: Logged |
posted
SLSE: SOLOS ENDOSCOPY INC - 10/18/2006 5:49:28 AM ET Price *Change *% Change Bid [tick] Ask BxA Size Open Volume 0.20 0.00 0% 0.15 [-] 0.35 5000 x 5000 0.00 0 * Calculations (Change and % Change) based on previous day's close
click on the solos# symbol on your account home page. may be showing just until it settles and then it should switch over to SLSE. IMO - would need to call the brokers to verify but this is just going to sit there for a year or so to see if it was worth the effort.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?
IP: Logged |
posted
I CANT FIND ANY PR AT ALL THAT SAYS HOW LONG THEY WILL BE RESTRCITED.
MAYBE ONE YEAR.
THOUGHTS ?
Press Release Source: Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. Establishes Record Date for Solos Endoscopy Stock Dividend Monday July 24, 8:31 am ET
Lifeline Shareholders to Be Issued a Solos Endoscopy Stock Dividend Based on the Shares They Hold as of August 18th
RENO, NV--(MARKET WIRE)--Jul 24, 2006 -- Lifeline Biotechnologies, Inc. (Other OTC:LBTN.PK - News) today announced that it has established the record date for the issuance of a special stock dividend to its shareholders. Lifeline Biotechnologies, Inc. shareholders of record as of August 18th, 2006 will receive 1 new share of Solos Endoscopy, Inc. (Other OTC:SLSE.PK - News) for approximately every 100 shares of LBTN they own as of the record date. Lifeline Biotechnologies shareholders will maintain their stock ownership of LBTN and will receive a dividend in Solos Endoscopy, Inc., a leading medical instrumentation company with worldwide distribution to major hospitals, surgical centers, and physician's offices. For each shareholder, as of the record date August 18th, 2006, Lifeline will deliver an Information Statement under the Securities Exchange Act of 1934 describing the terms and conditions of the special dividend distribution and the business of Solos Endoscopy.
ADVERTISEMENT
Solos Endoscopy, Inc. has obtained medical assets from Lifeline Biotechnologies Inc for $4 million in restricted shares of Solos Endoscopy, Inc. The medical assets will include the MastaScope(TM), First Warning System(TM), OvaScope(TM), and the inventory and intellectual properties relating to those products. Lifeline Biotechnologies will also receive compensation, in the form of a royalty, once sales of the MastaScope(TM), First Warning System(TM), and OvaScope(TM) exceed $4 million.
"This Dividend is a bonus for our loyal shareholders. The dividend will give our shareholders ownership in Solos Endoscopy, which in turn will allow them to still have an investment in the medical technology that Lifeline created," stated Jim Holmes, President of Lifeline Biotechnologies.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com.
About Lifeline Biotechnologies, Inc.:
Lifeline Biotechnologies develops and acquires undervalued companies which have innovative technology in the Medical, Nutraceutical, and Energy Industries, to increase the growth of the Company. Lifeline Biotechnologies continues to seek out and capitalize on emerging technologies that will change the medical community.
More information is available at the company's website: www.lbtn.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Contact: Contact: Big Apple Consulting USA, Inc. (for Lifeline Biotechnologies, Inc.) Investor Relations 407-884-0444 or 1-866-THE-APPLE
-------------------------------------------------------------------------------- Source: Lifeline Biotechnologies, Inc.
-------------------- All I say is IMHO.
I like these calm little moments before the storm... Reminds me of Bethoven
IP: Logged |
posted
I'd have to look through the old lbtn thread but these were not supposed to be restricted at all. could it just be a settlement issue until they verify all have been issued?
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?
IP: Logged |
posted
"BOSTON, MA--(MARKET WIRE)--Aug 2, 2006 -- Solos Endoscopy, Inc. and Lifeline Biotechnologies, Inc. (Other OTC:LBTN.PK - News) today announced the Company has acquired the Lifeline Biotechnologies' early cancer detection product line for $4 Million in restricted shares of Solos Endoscopy." Guess they were restricted eh? not sure how long though. pps is going down anyway. volume tells me no one new is selling.
my broker is looking into it now so it's not obvious whatever it is.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?
IP: Logged |
"Lifeline Biotechnologies' shareholders are expected to receive approximately 1 share of SLSE stock for every 100 shares of LBTN stock owned by August 18, 2006. Lifeline " http://biz.yahoo.com/iw/060815/0154308.html
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!?
IP: Logged |
posted
Lifeline Biotechnologies, Inc. Reports Operating Profits in Excess of $2,000,000 for the First Three Quarters of 2006 via COMTEX
November 1, 2006
RENO, NV, Nov 01, 2006 (MARKET WIRE via COMTEX News Network) --
Lifeline Biotechnologies, Inc. (PINKSHEETS: LBTN) today announced that the Company has reported operating profits of $2,012,098 for the first three quarters of 2006. Lifeline Biotechnologies' unaudited financial statements also show revenues of $2.7 Million, which were generated by the sale of Lifeline's medical products to Solos Endoscopy and other operating sources.
Lifeline Biotechnologies received Solos Endoscopy (PINKSHEETS: SLSE) common stock in exchange for the Company's medical products line. Lifeline recently distributed approximately 13 million shares to qualified (record date 8/18/06) owners of LBTN common stock. Earlier this year, Lifeline Biotechnologies changed its business strategy to include opportunities beyond the medical industry and began to focus on acquiring interest in the Alternate Energy Field.
"This is an exciting day for our Company and our shareholders, as we realize a significant growth in profits, as a result of our years of hard work and commitment. We will continue to seek out revolutionary new medical and alternative energy companies that we can invest in and benefit from," stated Jim Holmes, CEO of Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. recently announced that it received approximately 8.3 million shares of TrendSetter Solar Products (PINKSHEETS: TSSP) which represents more than $400,000 in total value which will be added to the company's balance sheet. The acquisition of TrendSetter Solar Products is part of Lifeline's strategy to increase shareholder value by improving its asset valuation and the potential of issuing dividends to its shareholders.
About Lifeline Biotechnologies, Inc.:
Lifeline Biotechnologies develops and acquires undervalued companies which have innovative technology in the medical, nutraceutical, and energy industries, to increase the growth of the Company. Lifeline Biotechnologies continues to seek out and capitalize on emerging technologies that will change the medical, nutraceutical, and energy community. More information is available at the company's website: www.lbtn.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
CONTACT: Lifeline Biotechnologies, Inc. Investor Relations 407-884-0444 or 1-866-THE-APPLE
SOURCE: Lifeline Biotechnologies, Inc.
Copyright 2006 Market Wire, All rights reserved.
Print story Current Quote OTO: LBTN Last: 0.000 Change: N/A Volume: N/A Day High: N/A Day Low: N/A
First Alert News Get real-time LBTN release alerts by entering your email address below.
IP: Logged |